Mareike Verbeek

Ismaninger Str. 22
Munich, BY 81675, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Discontinuing Ciprofloxacin Prophylaxis in Allogeneic Stem Cell Transplantation Does Not Result in Inferior Outcomes.

Discontinuing Ciprofloxacin Prophylaxis in Allogeneic Stem Cell Transplantation Does Not Result in Inferior Outcomes.

Journal: Transplantation and cellular therapy

Published: April 26, 2026

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.

Journal: Bone marrow transplantation

Published: December 25, 2025

Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT.

Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT.

Journal: American journal of hematology

Published: October 10, 2025

Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group.

Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group.

Journal: Transplantation and cellular therapy

Published: September 10, 2025

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Journal: Bone marrow transplantation

Published: September 05, 2025

Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Journal: Bone marrow transplantation

Published: July 24, 2025

Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.

Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.

Journal: Bone marrow transplantation

Published: July 01, 2025

Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey.

Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey.

Journal: Bone marrow transplantation

Published: January 31, 2025

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.

Journal: Blood cancer journal

Published: January 07, 2025

Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation.

Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation.

Journal: Blood advances

Published: September 09, 2024

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis.

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis.

Journal: Bone marrow transplantation

Published: August 04, 2024

CXCR4-directed endoradiotherapy with [177Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia.

CXCR4-directed endoradiotherapy with [177Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia.

Journal: Theranostics

Published: July 20, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026